Context:
Like many other major patentees, InterDigital last year began enforcing its cellular standard-essential patents (SEPs) against China’s Transsion, the African market leader and a major player in other price-sensitive markets such as Latin America (
October 31, 2025
ip fray
article
Context:
In January 2026, the UPC’s Paris Local Division (LD) dismissed Guardant Health, Inc.’s application for provisional measures against the Sophia Genetics group, finding that
EP3443066
(“Methods for early detection of cancer”) was more likely than not invalid for added matter. It is a unitary patent directed to a method for detecting colorectal, ovarian, lung, or pancreatic cancer by sequencing circulating cell-free DNA (cfDNA). It was granted on October 2, 2024, claims priority from April 14 and April 18, 2016, is in force in Switzerland, Spain, and the UK, and has not been opposed. It ordered Guardant to pay Sophia an interim costs award of €400,000 (
January 29, 2026
Context:
Access Advance operates several pools containing standard-essential patents (SEPs) relevant to major video codecs. It announced a royalty rate increase last year, offering an early-bird 25% rate reduction until this week (
January 27, 2026
ip fray
article